Liu Ruonan, Zhang Jing, Chen Si, Xiao Yang, Hu Jingyi, Zhou Zhiguang, Xie Lingxiang
National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal University, Changsha, China.
Diabetes Obes Metab. 2025 Mar;27(3):1045-1064. doi: 10.1111/dom.16101. Epub 2024 Dec 1.
Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by T cell-mediated pancreatic β cell loss, resulting in lifelong absolute insulin deficiency and hyperglycaemia. Environmental factors are recognized as a key contributor to the development of T1D, with the gut serving as a primary interface for environmental stimuli. Recent studies have revealed that the alterations in the intestinal microenvironment profoundly affect host immune responses, contributing to the aetiology and pathogenesis of T1D. However, the dominant intestinal immune cells and the underlying mechanisms remain incompletely elucidated. In this review, we provide an overview of the possible mechanisms of the intestinal mucosal system that underpin the pathogenesis of T1D, shedding light on the roles of both non-classical and classical immune cells in T1D. Our goal is to gain insights into how modulating these immune components may hold potential implications for T1D prevention and provide novel perspectives for immune-mediated therapy.
1型糖尿病(T1D)是一种慢性自身免疫性疾病,其特征是T细胞介导的胰腺β细胞丢失,导致终身绝对胰岛素缺乏和高血糖。环境因素被认为是T1D发病的关键因素,肠道是环境刺激的主要界面。最近的研究表明,肠道微环境的改变深刻影响宿主免疫反应,促成了T1D的病因和发病机制。然而,主要的肠道免疫细胞及其潜在机制仍未完全阐明。在本综述中,我们概述了肠道黏膜系统支持T1D发病机制的可能机制,阐明了非经典和经典免疫细胞在T1D中的作用。我们的目标是深入了解调节这些免疫成分如何可能对T1D预防具有潜在意义,并为免疫介导的治疗提供新的视角。